University of Alberta
Edmonton, Alberta, T6G2B7, Canada
NCT Number: NCT04571177
Adult patients who are diagnosed with an acute supratentorial ischemic stroke within 48 hrs of onset will be enrolled into the study. Participants will undergo both a CT Scan and PET scan within 7 days of onset. Participants will have the option to undergo a second PET scan with fluorodeoxyglucose (FDG).
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Edmonton, Alberta, T6G2B7, Canada
Patients older than 18 years of age diagnosed with an acute supratentorial ischemic stroke within 48 hrs of symptom onset will be prospectively enrolled. Research imaging will be obtained before 7 days after symptom onset. The patient will receive the standardized treatment protocol at the hospital. Informed consent will be obtained from each patient or a substitute decision maker for each individual imaging study (CTP, Rb PET, and FDG PET). The patient will be given the option of undergoing the CTP imaging with the Rb PET only or both the Rb PET and FDG PET components.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, 1 year from start of recruitment
Imaging of CTP images with the Rb PET only or both the Rb PET and FDG PET with CTP imaging components to evaluate blood flow and metabolism mismatches.
University of Alberta
Other
Developing PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07233070
Acute Ischemic Stroke, Brain Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07626541
Acute Ischemic Stroke, Brain Diseases
Xuzhou, Jiangsu, China
View Trial DetailsNCT07263776
Acute Ischemic Stroke, Brain Diseases
Suzhou, Anhui, China
View Trial DetailsNCT07271082
Acute Ischemic Stroke, Behavior
Fuyang, Anhui, China
View Trial Details